Effect of tranilast on bleomycin induced pulmonary fibrosis in a rat model

Abstract

This study aimed to investigate the effect and mechanism of tranilast (TR) on bleomycin (BLM) induced pulmonary fibrosis in a rat model, pulmonary fibrosis was induced in rats by using intratracheal bleomycin and the serum and lungs were collected 28 days later. The serum levels of IL-4 and IFNwere determined by ELISA and IL-4/IFN-was calculated. Reverse transcription polymerase chain reaction (RT-PCR) was employed to measure the mRNA expression of TGF-1. Immunohistochemistry was employed to detect the protein expression of TGF-1 followed by evaluation of alveolitis and fibrosis. When compared with BLM group and glucocorticoid (GC) group, the INF-level was markedly increased and IL-4 level dramatically decreased in the TR group with a significant decrease of IL-4/INFratio. The mean optical density and mRNA expression of TGF-1 were markedly decreased accompanied by low scores of alveolitis and fibrosis. Significant differences were observed between TR groups (medium and high dose) and BLM group as well as control group (P < 0.05) in the aforementioned parameters. Moreover, marked difference was also observed among TR groups (P < 0.05) in the aforementioned parameters. Both TR and GC can affect the Th1/Th2 lymphocyte balance and inhibit the TGF-1 expression improving the BLM induced pulmonary fibrosis.

N-Acetylcysteine attenuated pulmonary fibrosis induced by bleomycin via immunomodulation responses

“…However, bleomycin is associated with producing transforming growth factor beta (TGF-β) protein in fibroblast proliferation and PF development( 10 ). At the present, N-acetyl cysteine (NAC) as an antioxidant, as well as vitamin E and bilirubin are given to remove free radicals and prevent inflammatory processes in PF( 11 12 13 14 15 16 ).…”